Difference between revisions of "Part:BBa K2978000:Design"
Line 13: | Line 13: | ||
===Source=== | ===Source=== | ||
− | + | Synthesized <i>de novo</i> with codon optimization for <i>E.coli</i>. The sequence was obtained from Wang <i>et al.</i> work (2015). | |
===References=== | ===References=== | ||
+ | Wang, Q., Euler, C. W., Delaune, A. & Fischetti, V. A. (2015). Using a Novel Lysin To Help Control <i>Clostridium difficile</i> Infections. <i>Antimicrobial Agents and Chemotherapy</i>, 59(12), 7447–7457. doi:10.1128/aac.01357-15 |
Revision as of 18:10, 10 October 2019
Causes cell lysis of the pathogen Clostridium difficile
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Need to be express in a chassis that contains the T7 polymerase
Source
Synthesized de novo with codon optimization for E.coli. The sequence was obtained from Wang et al. work (2015).
References
Wang, Q., Euler, C. W., Delaune, A. & Fischetti, V. A. (2015). Using a Novel Lysin To Help Control Clostridium difficile Infections. Antimicrobial Agents and Chemotherapy, 59(12), 7447–7457. doi:10.1128/aac.01357-15